Endogenous IL-33 Suppresses Lung Cancer Cell Apoptosis via ERK1/2 Pathway

Society

‌
‌

AI summary

Display highlights

Endogenous IL-33 inhibits lung cancer cell apoptosis via ERK1/2 pathway
Genetic manipulation using lentivirus and siRNA
IL-33 affects cell proliferation, migration, invasion, and apoptosis
Various techniques used for protein and gene expression analysis
IL-33 regulates BCL2/BAX ratio to suppress apoptosis

Explore

The above information is compiled by nature.com and does not represent any position of Arbor. It does not constitute any investment advice made by Arbor. Before making any investment decisions, investors should consider the risk factors related to the investment products based on their own circumstances and seek advice from professional investment advisors if necessary. We strive to ensure but cannot guarantee the truthfulness, accuracy, and originality of the above content, and we make no promises or guarantees in this regard. As machine learning has a probabilistic nature, it may lead to incorrect reflection of facts in certain situations. You should appropriately evaluate the accuracy of any information summary based on your usage, including through manual evaluation of the information summary. We are not responsible for any losses or liabilities incurred by you due to your use, viewing, and access of the platform or failure to do so.

Remove Duplicated Information

Less is More

Applicable for iOS and Android systems

Endogenous IL-33 Suppresses Lung Cancer Cell Apoptosis via ERK1/2 Pathway

Berkshire's Cash Pile Grows to $334 Billion, Greg Abel Prepared for Investments

Supreme Court Temporarily Halts Trump's Removal of Federal Watchdog Head

Exciting Updates Coming in iOS 18.4 Beta

Remove Duplicated Information